Who
Christopher A. Kuebler
Director
Company insider
Files Form 4 as: Director, Waters; Director, Nektar Therapeutics; Chairman, Covance.
In numbers
- Trades disclosed
- 173
- Buys
- 0
- Sells
- 21
- Bought
- $0
- Sold
- $19.9M
- Companies
- 3
- Companies where not an officer
- 2
- First trade
- 30 Dec 2005
- Last trade
- 6 Aug 2026
- Last filed
- 7 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 6 Aug 2026filed 7 Aug 2026 | WAT WatersLife-science tools | SEC FORM 4 Code M | $495K3,626 at $136.43 | filing |
| 6 Aug 2026filed 7 Aug 2026 | WAT WatersLife-science tools | SEC FORM 4 Sold | $1.4M3,626 at $397.94 | filing |
| 6 Aug 2026filed 7 Aug 2026 | WAT Watersoption or derivative · Life-science tools | SEC FORM 4 Code M | —3,626 at $0.00 | filing |
| 6 Aug 2026filed 7 Aug 2026 | WAT Watersoption or derivative · Life-science tools | SEC FORM 4 Code M | —3,626 at $0.00 | filing |
| 6 Aug 2026filed 7 Aug 2026 | WAT WatersLife-science tools | SEC FORM 4 Code M | $495K3,626 at $136.43 | filing |
| 6 Aug 2026filed 7 Aug 2026 | WAT WatersLife-science tools | SEC FORM 4 Sold | $1.4M3,626 at $397.94 | filing |
| 25 Feb 2026filed 27 Feb 2026 | WAT WatersLife-science tools | SEC FORM 4 Code A | —23 at $0.00 | filing |
| 25 Feb 2026filed 27 Feb 2026 | WAT Watersoption or derivative · Life-science tools | SEC FORM 4 Code A | —57 at $0.00 | filing |
| 25 Feb 2026filed 27 Feb 2026 | WAT Watersoption or derivative · Life-science tools | SEC FORM 4 Code A | —57 at $0.00 | filing |
| 25 Feb 2026filed 27 Feb 2026 | WAT WatersLife-science tools | SEC FORM 4 Code A | —23 at $0.00 | filing |
| 2 Jan 2026filed 5 Jan 2026 | WAT WatersLife-science tools | SEC FORM 4 Code A | —307 at $0.00 | filing |
| 2 Jan 2026filed 5 Jan 2026 | WAT Watersoption or derivative · Life-science tools | SEC FORM 4 Code A | —828 at $0.00 | filing |
| 2 Jan 2026filed 5 Jan 2026 | WAT Watersoption or derivative · Life-science tools | SEC FORM 4 Code A | —828 at $0.00 | filing |
| 2 Jan 2026filed 5 Jan 2026 | WAT WatersLife-science tools | SEC FORM 4 Code A | —307 at $0.00 | filing |
| 5 Nov 2025filed 7 Nov 2025 | WAT Watersoption or derivative · Life-science tools | SEC FORM 4 Code M | —3,761 at $0.00 | filing |
| 5 Nov 2025filed 7 Nov 2025 | WAT WatersLife-science tools | SEC FORM 4 Code M | $490K3,761 at $130.35 | filing |
| 5 Nov 2025filed 7 Nov 2025 | WAT WatersLife-science tools | SEC FORM 4 Code F | $490K1,318 at $371.97 | filing |
| 2 Jan 2025filed 6 Jan 2025 | WAT Watersoption or derivative · Life-science tools | SEC FORM 4 Code A | —818 at $0.00 | filing |
| 2 Jan 2025filed 6 Jan 2025 | WAT WatersLife-science tools | SEC FORM 4 Code A | —319 at $0.00 | filing |
| 15 May 2024filed 16 May 2024 | WAT Watersoption or derivative · Life-science tools | SEC FORM 4 Code M | —4,000 at $0.00 | filing |
News
Ultima Genomics Selected for Landmark Large-Scale Immune Profiling Study with IMU Biosciences, UK Biobank and Waters CorporationWAT · prnewswire.com · 19 Oct 2026Waters Launches AI Link, Advancing AI-Enabled LC-MS Workflows from Research to ReleaseWAT · manilatimes.net · 13 Oct 2026New CellCarta and Waters partnership advances diagnosticsWAT · selectscience.net · 13 Oct 2026
0 headlines in the last 90 days name Christopher A. Kuebler; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.